Antigua and Barbuda vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB
Antigua and Barbuda
100.0%
in 2022
Western Pacific (WHO region)
86.0%
in 2024
Antigua and Barbuda rank
1st
Western Pacific (WHO region) rank
3rd
Previously treated cases tested for RR-/MDR-TB over time
- Antigua and Barbuda
- Western Pacific (WHO region)
How they compare
Antigua and Barbuda currently reports 100.0% against 86.0% in Western Pacific (WHO region), a difference of 14.0%.
That makes Antigua and Barbuda's figure about 1.2 times Western Pacific (WHO region)'s.
The two have swapped places 2 times across 5 shared years of data; in 2009 it was Antigua and Barbuda ahead.
Antigua and Barbuda ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
Across the 3 decades both report, Antigua and Barbuda averaged higher in 2 and Western Pacific (WHO region) in 1.
Head to head by decade
| Decade | Antigua and Barbuda | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 1.0% | 49.0% | Antigua and Barbuda |
| 2010s | 0.0% | 21.1% | 21.1% | Western Pacific (WHO region) |
| 2020s | 100.0% | 83.0% | 17.0% | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Antigua and Barbuda or Western Pacific (WHO region)?
- Antigua and Barbuda, at 100.0% against 86.0% in Western Pacific (WHO region) as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Antigua and Barbuda and Western Pacific (WHO region)?
- 14.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Western Pacific (WHO region)?
- 5 years are reported by both, from 2009 to 2022.
- How do Antigua and Barbuda and Western Pacific (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Antigua and Barbuda ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.